Predictive Modeling Of Alzheimer’s Disease Risk And The Simulated Long -Term Impact Of Covid-19 Severity.

Authors

  • Y. Ebenezer PonSelvi
  • V. Joseph Peter

Keywords:

Alzheimer’s Disease, Neurodegenerative disorder, Post-COVID profiles, Cognitive sequelae, Predictive Modeling, Machine Learning

Abstract


Alzheimer's disease (AD) is a profoundly challenging neurodegenerative disorder[2], and an expanding body of clinical literature increasingly links the post-acute sequelae of COVID-19 to long-term neurological and cognitive deficits. This computational inquiry investigates the potential impact of long-COVID conditions on the latent risk of developing AD using an advanced machine learning framework. A comprehensive clinical Alzheimer's disease dataset was leveraged for model training and feature extraction[3], while empirical insights from a COVID-19 symptom and cognitive impact dataset were utilized to construct multi-tiered simulated patient profiles. Three distinct classification algorithms—Random Forest[2], Logistic Regression[3], and XGBoost—were trained to predict AD likelihood, with the XGBoost Classifier emerging as the superior predictive model[7]. Feature importance analysis highlighted functional assessments, Activities of Daily Living (ADL), and specific cognitive state examinations as the primary computational drivers of predicted decline[2]. By deploying the trained models against hypothetical post-COVID profiles ranging from mild to severe impairment, a distinct escalation in the predicted Alzheimer's risk probability was observed as post-COVID health markers deteriorated. These findings suggest a compelling structural vulnerability for accelerated cognitive decline in individuals experiencing severe long-term post-COVID conditions[9]. However, because this machine learning simulation serves as an indirect proxy[2], these results underscore an urgent mandate for prospective longitudinal clinical studies to establish definitive causal pathways between viral-induced sequelae and neurodegenerative outcomes[8]..



Downloads

Download data is not yet available.

References

[1] Bello-Corral, L. (2025). Evaluating the link between cardiovascular risk and Alzheimer's disease: A comprehensive case-control study in Castilla y León, Spain. Applied Sciences, 15(6), 3409.

[2] Dunk, M. M., & Driscoll, I. (2021). Total cholesterol and APOE-related risk for Alzheimer’s disease in the Alzheimer’s Disease Neuroimaging Initiative. Journal of Alzheimer’s Disease, 85(4), 1519–1528. https://doi.org/10.3233/jad-215091

[3] Emeç, M. (2025). Prediction of Alzheimer's diagnosis with machine learning and innovative feature engineering. Academic Platform Journal of Engineering and Smart Systems, 13(2), 112–124.

[4] Hossain, M. K. (2025). Optimizing Alzheimer's disease prediction through ensemble learning and feature interpretability with SHAP-based feature analysis. Brain and Behavior, 15(8), e12338. https://doi.org/10.1002/brb3.12338

[5] Hunsberger, H. C., Pinky, P. D., Smith, W., Suppiramaniam, V., & Reed, M. N. (2019). The role of APOE4 in Alzheimer’s disease: Strategies for future therapeutic interventions. Neuronal Signaling, 3(2), NS20180203. https://doi.org/10.1042/ns20180203

[6] Malar, D. S., Thitilertdecha, P., Ruckvongacheep, K. S., Brimson, S., Tencomnao, T., & Brimson, J. M. (2023). Targeting sigma receptors for the treatment of neurodegenerative and neurodevelopmental disorders. CNS Drugs, 37(5), 399–440. https://doi.org/10.1007/s40263-023-01007-6

[7] Nouraeinejad, A. (2023). The link between COVID-19 and Alzheimer disease through neuroinflammation. Clinical Medicine & Research, 21(2), 119–121. https://doi.org/10.3121/cmr.2023.1841

[8] Popa, E. (2025). The molecular mechanisms of cognitive dysfunction in Long COVID: A narrative review. International Journal of Molecular Sciences, 26(11), 5102. https://doi.org/10.3390/ijms26115102

[9] Toups, K. (2022). Precision medicine approach to Alzheimer's disease: Successful pilot project. Journal of Alzheimer's Disease, 88(4), 1411–1421

Downloads

Published

2025-06-23

How to Cite

1.
PonSelvi YE, Peter VJ. Predictive Modeling Of Alzheimer’s Disease Risk And The Simulated Long -Term Impact Of Covid-19 Severity. J Neonatal Surg [Internet]. 2025 Jun. 23 [cited 2026 Aug. 25];14(30S):1172-80. Available from: https://jneonatalsurg.com/index.php/jns/article/view/10384